Paige.AI, Inc

Paige.AI is a clinical AI software company specializing in computational pathology for cancer diagnostics and biomarker discovery. The company develops AI-assisted diagnostic applications and foundation models for histopathology analysis, enabling pathologists to detect, subtype, and identify molecular biomarkers from tissue samples. Core product lines include the Paige Prostate Suite, Paige Breast Suite, Paige GI Suite, and Paige PanCancer Suite—all designed to support cancer detection and classification on H&E-stained whole-slide images. The company licenses advanced foundation models (Virchow, Virchow2, Virchow2G, Virchow2G-Mini, and PRISM) to partners for custom AI development in cancer care. Paige Alba is a proprietary co-pilot platform integrating voice and text interfaces with AI diagnostics to streamline pathology workflows. The company provides comprehensive services including custom AI development, regulatory strategy consulting, and commercialization support. Paige's technology is trained cumulatively on over 1.5 million slides and designed to address diagnostic scalability and workload pressures in clinical pathology settings. The firm serves pharmaceutical, life sciences, research, and healthcare provider organizations globally.